Lantern Pharma
Quarterly Financials
| Values in thousands | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -3 | 4 | -4 | -4 |
EBITDA | -3,401 | -4,198 | -4,345 | -4,647 |
EBIT | -3,405 | -4,202 | -4,349 | -4,651 |
Net Income | -3,329 | -4,074 | -4,177 | -4,331 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -3,772 | -2,792 | -4,572 | -3,937 |
Cash | 4,917 | 4,422,838 | 8,389 | 6,061 |
Basic Shares | 11,253 | 10,898 | 10,833 | 10,784 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -17 | -190 | -174 | -154 |
EBITDA | -17,961 | -22,199 | -15,786 | -14,422 |
EBIT | -17,978 | -22,216 | -15,961 | -14,432 |
Net Income | -17,119 | -20,781 | -15,961 | -14,259 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Cost of Revenue | -14,770 | |||
Free Cash Flow | -15,678 | -17,825 | -14,365 | -12,795 |
Cash | 4,422,838 | 7,511 | 21,937 | 37,201 |
Basic Shares | 10,898 | 10,762 | 10,842 | 10,850 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | -$0.30 |
2025-12-31 | -$0.36 |
2025-09-30 | -$0.39 |
2025-06-30 | -$0.40 |